comparemela.com

Walterh Kaye News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anorexia Nervosa And Psilocybin Therapy As A Potential Helping Hand: First Published Clinical Trial Results - Compass Pathways (NASDAQ:CMPS)

UC-San Diego authors assessed psilocybin therapy’s potential as a treatment for anorexia nervosa. They recently shared what are believed to be the first results from such a research study, and the findings look promising.

COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa

Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological

COMPASS Pathways launches phase II clinical trial of

Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.